-
Mashup Score: 30
A new study shows patients with glioblastoma experienced improved overall survival after undergoing a novel approach to treatment.
Source: newsnetwork.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Patients with glioblastoma experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, researchers have reported.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
For patients with #glioblastoma, the most common malignant brain tumor, they experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, which resulted in T-cell expansion and clonal replacement, study findings showed. https://t.co/JJ8eXS7TNO
-
-
Mashup Score: 0Optune Plus Temodar and Keytruda May Result in Brain Tumor Control - 1 month(s) ago
Patients with glioblastoma experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, researchers have reported.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
For patients with #glioblastoma, the most common malignant brain tumor, they experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, which resulted in T-cell expansion and clonal replacement, study findings showed. https://t.co/JJ8eXS7TNO
-
-
Mashup Score: 16
Thanks to funding from NCI’s Small Business Innovation Research program, a new tool recently received FDA clearance. See how this cyber device could help you with artificial intelligence (AI)-guided glioblastoma segmentation.
Source: datascience.cancer.govCategories: General Medicine News, Oncologists1Tweet-
A new tool for measuring and labeling #glioblastoma brain tumors recently received @US_FDA clearance. The tool, called i2Contour, was developed with support from NCI's Small Business Innovation Research (SBIR) program. Read more: https://t.co/eTVWqpHags https://t.co/Vw7VZIvyEB
-
-
Mashup Score: 8Study explores novel therapeutic treatment for glioblastoma - 2 month(s) ago
Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James and Richard J. Solove Research Institute are trying to improve
Source: cancer.osu.eduCategories: General Medicine News, Hem/OncsTweet-
#Glioblastoma comes with a number of treatment challenges, so it’s great to see this @OSUCCC_James research into a new therapy with dual focuses. https://t.co/73XASHgZjQ
-
-
Mashup Score: 1
Disclosures. Gentner:GENENTA SCIENCE: Consultancy, Current equity holder in publicly-traded company, Research Funding. Brambilla:GENENTA SCIENCE: Current E
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Temferon has reported promising efficacy and safety results in pts with #glioblastoma https://t.co/t7ksc4pPah
-
-
Mashup Score: 8Scientists explore new mechanisms to combat glioblastoma - 2 month(s) ago
Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet-
Scientists explore new mechanisms to combat #glioblastoma @northwesternu @cell_metabolism @jclinicalinvest @NatureComms https://t.co/bu3udO4pYg
-
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet-
Arming natural killer cells with interleukin-21 endows them with enhanced and long-lasting anti-tumor activity against #glioblastoma stem cell-like cells, according to new research. https://t.co/V21lTZXU5c https://t.co/L7FUI6poXj
-
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet-
Arming natural killer cells with interleukin-21 endows them with enhanced and long-lasting anti-tumor activity against #glioblastoma stem cell-like cells, according to new research. https://t.co/V21lTZXU5c https://t.co/L7FUI6poXj
-
-
Mashup Score: 2Informed Consent from Patients With Glioblastoma Is a ‘Big Thing’ - 4 month(s) ago
For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
After receiving a diagnosis of #Glioblastoma, obtaining proper information and education about the disease and treatment options is key before providing doctors with informed consent, said Dr. Stephanie E. Weiss of @FoxChaseCancer. https://t.co/AI2J9yLTLy
-
Currently there is no cure for #glioblastoma, but results of a new study conducted at Mayo Clinic show patients experienced improved overall survival while maintaining quality of life after undergoing a novel approach to treatment. Learn more: https://t.co/ult3mgn2Ay https://t.co/lJ2801UuJe